AUXILIUM PHARMACEUTICALS INC Operating Cash Flow
AUXILIUM PHARMACEUTICALS INC reported Operating Cash Flow of $8.24 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-05-10
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was $8.24M, a 97.03% increase year-over-year.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $4.59M.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was $299.00K.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-06-30 was $21.62M.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was $30.70M.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was -$48.89M.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2009 was -$41.36M, a 188.55% decline from fiscal 2008.
- AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2008 was $46.71M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-03-31 | $8.24M 10-Q · filed 2012-05-10 | $12.83M derived: sum of 2 quarters · filed 2012-05-10 | $13.13M derived: sum of 3 quarters · filed 2012-05-10 | $34.76M derived: sum of 4 quarters · filed 2012-05-10 |
| 2011-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $4.89M derived: sum of 2 quarters · filed 2012-02-29 | $26.52M derived: sum of 3 quarters · filed 2012-02-29 | $30.70M 10-K · filed 2012-02-29 |
| 2011-09-30 | $299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $21.92M derived: sum of 2 quarters · filed 2011-11-09 | $26.10M 10-Q · filed 2011-11-09 | $12.78M derived: sum of 4 quarters · filed 2012-05-10 |
| 2011-06-30 | $21.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02 | $25.80M 10-Q · filed 2011-08-02 | $12.48M derived: sum of 3 quarters · filed 2012-05-10 | -$6.69M derived: sum of 4 quarters · filed 2012-05-10 |
| 2011-03-31 | $4.18M 10-Q · filed 2012-05-10 | -$9.15M derived: sum of 2 quarters · filed 2012-05-10 | -$28.31M derived: sum of 3 quarters · filed 2012-05-10 | -$39.37M derived: sum of 4 quarters · filed 2012-05-10 |
| 2010-12-31 | -$13.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$32.49M derived: sum of 2 quarters · filed 2012-02-29 | -$43.55M derived: sum of 3 quarters · filed 2012-02-29 | -$48.89M 10-K · filed 2012-02-29 |
| 2010-09-30 | -$19.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$30.22M derived: sum of 2 quarters · filed 2011-11-09 | -$35.56M 10-Q · filed 2011-11-09 | -$44.98M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | -$11.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02 | -$16.40M 10-Q · filed 2011-08-02 | -$25.82M derived: sum of 3 quarters · filed 2012-02-29 | -$28.36M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | -$5.34M 10-Q · filed 2011-05-10 | -$14.76M derived: sum of 2 quarters · filed 2012-02-29 | -$17.30M derived: sum of 3 quarters · filed 2012-02-29 | |
| 2009-12-31 | -$9.42M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$11.96M derived: sum of 2 quarters · filed 2012-02-29 | -$41.36M 10-K · filed 2012-02-29 | |
| 2009-09-30 | -$2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$31.94M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | -$29.40M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $46.71M 10-K · filed 2011-03-01 |